FMP
Turnstone Biologics Corp.
TSBX
NASDAQ
Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, and uveal melanoma, as well as an investigator sponsored trial to treat cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.
0.454 USD
0.0016 (0.353%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Dr. Sammy J. Farah M.B.A., Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://turnstonebio.comexchange
NASDAQ
Description
Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, and uveal melanoma, as well as an investigator sponsored trial to treat cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.
CIK
0001764974
ISIN
US90042W1009
CUSIP
90042W100
Address
9310 Athena Circle
Phone
347-897-5988
Country
US
Employee
80
IPO Date
Jul 21, 2023
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
TSBX Financial Summary
CIK
0001764974
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
90042W100
ISIN
US90042W1009
Country
US
Price
0.45
Beta
0
Volume Avg.
272.86k
Market Cap
10.49M
Shares
-
52-Week
0.403-5.75
DCF
-1.38
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.2
P/B
-
Website
https://turnstonebio.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest TSBX News
It looks like there's no news available.
